Avi Dukler, PhD
Biotechnologist, Business Leader, SAB Member
Dr. Dukler is a healthcare business leader who focuses on new applications for digital health, personalized medicine, and molecular diagnostics. He received his PhD in biotechnology and B.Sc. in Life Sciences from the Tel Aviv University in Israel.
During his 23+ years in the diagnostics industry, Dr. Dukler co-founded Kepler Diagnostics, Inc, Fantestico Inc, and Glycominds Ltd., where he commercialized innovative digital health and clinical diagnostics products.
Dr. Dukler led Glycominds IPO in 2011 at TASE and structured a strategic deal with LabCorp (NYSE: LH). Dr. Dukler is an inventor and author of multiple patents and scientific publications, completed several transactions including M&A, asset sales, IP licenses, private and public fundraising.